Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1987 1
1994 2
1995 7
1996 9
1997 2
1999 2
2000 4
2001 4
2002 12
2003 7
2004 7
2005 11
2006 8
2007 9
2008 15
2009 22
2010 16
2011 16
2012 18
2013 16
2014 9
2015 10
2016 16
2017 8
2018 11
2019 9
2020 16
2021 15
2022 6
2023 7
2024 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

276 results

Results by year

Filters applied: . Clear all
Page 1
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML; CGC; Karlan BY, Khan S, Klein C, Kohlmann W; CGC; Kurian AW, Laronga C, Litton JK, Mak JS; LCGC; Menendez CS, Merajver SD, Norquist BS, Offit K, Pederson HJ, Reiser G; CGC; Senter-Jamieson L; CGC; Shannon KM, Shatsky R, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB, Darlow SD, Dwyer MA. Daly MB, et al. Among authors: merajver sd. J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102. doi: 10.6004/jnccn.2021.0001. J Natl Compr Canc Netw. 2021. PMID: 33406487
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
Daly MB, Pal T, Maxwell KN, Churpek J, Kohlmann W, AlHilli Z, Arun B, Buys SS, Cheng H, Domchek SM, Friedman S, Giri V, Goggins M, Hagemann A, Hendrix A, Hutton ML, Karlan BY, Kassem N, Khan S, Khoury K, Kurian AW, Laronga C, Mak JS, Mansour J, McDonnell K, Menendez CS, Merajver SD, Norquist BS, Offit K, Rash D, Reiser G, Senter-Jamieson L, Shannon KM, Visvanathan K, Welborn J, Wick MJ, Wood M, Yurgelun MB, Dwyer MA, Darlow SD. Daly MB, et al. Among authors: merajver sd. J Natl Compr Canc Netw. 2023 Oct;21(10):1000-1010. doi: 10.6004/jnccn.2023.0051. J Natl Compr Canc Netw. 2023. PMID: 37856201
Reply by Authors.
Abusamra SM, Solorzano MA, Luke M, Quarles J, Jacobs MF, Das S, Kasputis A, Okoth LA, Patel M, Seymore M, Caram MEV, Dunn RL, Merajver SD, Stoffel EM, Reichert ZR, Morgan TM. Abusamra SM, et al. Among authors: merajver sd. J Urol. 2022 Nov;208(5):1016-1017. doi: 10.1097/JU.0000000000002865.02. Epub 2022 Aug 19. J Urol. 2022. PMID: 35984085 No abstract available.
Engineered Tools to Study Intercellular Communication.
Yang BA, Westerhof TM, Sabin K, Merajver SD, Aguilar CA. Yang BA, et al. Among authors: merajver sd. Adv Sci (Weinh). 2020 Dec 21;8(3):2002825. doi: 10.1002/advs.202002825. eCollection 2021 Feb. Adv Sci (Weinh). 2020. PMID: 33552865 Free PMC article. Review.
Breast cancer risk reduction.
Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Lawton T, Loftus L, Macdonald DJ, Mahoney MC, Merajver SD, Seewaldt V, Sellin RV, Shapiro CL, Singletary E, Ward JH; National Comprehensive Cancer Network (NCCN). Bevers TB, et al. Among authors: merajver sd. J Natl Compr Canc Netw. 2007 Sep;5(8):676-701. J Natl Compr Canc Netw. 2007. PMID: 17927926 No abstract available.
Genetic determinants of aggressive breast cancer.
Ventura AC, Merajver SD. Ventura AC, et al. Among authors: merajver sd. Annu Rev Med. 2008;59:199-212. doi: 10.1146/annurev.med.59.060106.184830. Annu Rev Med. 2008. PMID: 17914925 Review.
Copper deficiency as an anti-cancer strategy.
Goodman VL, Brewer GJ, Merajver SD. Goodman VL, et al. Among authors: merajver sd. Endocr Relat Cancer. 2004 Jun;11(2):255-63. doi: 10.1677/erc.0.0110255. Endocr Relat Cancer. 2004. PMID: 15163301 Review.
Selective and Potent PROTAC Degraders of c-Src Kinase.
Mao W, Vandecan NM, Bingham CR, Tsang PK, Ulintz P, Sexton R, Bochar DA, Merajver SD, Soellner MB. Mao W, et al. Among authors: merajver sd. ACS Chem Biol. 2024 Jan 19;19(1):110-116. doi: 10.1021/acschembio.3c00548. Epub 2023 Dec 19. ACS Chem Biol. 2024. PMID: 38113191
Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer.
Achreja A, Yu T, Mittal A, Choppara S, Animasahun O, Nenwani M, Wuchu F, Meurs N, Mohan A, Jeon JH, Sarangi I, Jayaraman A, Owen S, Kulkarni R, Cusato M, Weinberg F, Kweon HK, Subramanian C, Wicha MS, Merajver SD, Nagrath S, Cho KR, DiFeo A, Lu X, Nagrath D. Achreja A, et al. Among authors: merajver sd. Nat Metab. 2022 Sep;4(9):1119-1137. doi: 10.1038/s42255-022-00636-3. Epub 2022 Sep 21. Nat Metab. 2022. PMID: 36131208
276 results